A note on performance metrics for the kidney failure risk equation
Nephrol Dial Transplant
.
2024 Apr 27:gfae098.
doi: 10.1093/ndt/gfae098.
Online ahead of print.
Authors
Oskar Ålund
1
,
Robert Unwin
2
,
Benjamin Challis
2
,
Philip A Kalra
3
,
Maarten W Taal
4
,
David C Wheeler
5
,
Simon D S Fraser
6
,
Paul Cockwell
7
,
Magnus Söderberg
1
Affiliations
1
AstraZeneca, Gothenburg, Sweden.
2
AstraZeneca, Cambridge, UK.
3
Dept of Renal Medicine, Salford Royal Hospital and University of Manchester, UK.
4
Centre for Kidney Research and Innovation, University of Nottingham.
5
Department of Renal Medicine, University College London.
6
School of Primary Care, Population Science and Medical Education, Faculty of Medicine, University of Southampton.
7
Department of Renal Medicine, Queen Elizabeth Hospital, University Hospitals of Birmingham, Birmingham, UK.
PMID:
38678004
DOI:
10.1093/ndt/gfae098
No abstract available